100 related articles for article (PubMed ID: 21867731)
1. Use of plethysmography in assessing the efficacy of antivirals in a mouse model of pandemic influenza A virus.
Julander JG; Hagloch J; Latimer S; Motter N; Dagley A; Barnard DL; Smee DF; Morrey JD
Antiviral Res; 2011 Nov; 92(2):228-36. PubMed ID: 21867731
[TBL] [Abstract][Full Text] [Related]
2. Activities of oseltamivir and ribavirin used alone and in combination against infections in mice with recent isolates of influenza A (H1N1) and B viruses.
Smee DF; Wong MH; Bailey KW; Sidwell RW
Antivir Chem Chemother; 2006; 17(4):185-92. PubMed ID: 17066897
[TBL] [Abstract][Full Text] [Related]
3. A single intramuscular injection of neuraminidase inhibitor peramivir demonstrates antiviral activity against novel pandemic A/California/04/2009 (H1N1) influenza virus infection in mice.
Bantia S; Kellogg D; Parker C; Upshaw R; Ilyushina NA; Babu YS
Antiviral Res; 2011 Apr; 90(1):17-21. PubMed ID: 21316393
[TBL] [Abstract][Full Text] [Related]
4. Simvastatin and oseltamivir combination therapy does not improve the effectiveness of oseltamivir alone following highly pathogenic avian H5N1 influenza virus infection in mice.
Belser JA; Szretter KJ; Katz JM; Tumpey TM
Virology; 2013 Apr; 439(1):42-6. PubMed ID: 23453580
[TBL] [Abstract][Full Text] [Related]
5. The combination of oseltamivir with azithromycin does not show additional benefits over oseltamivir monotherapy in mice infected with influenza A(H1N1)pdm2009 virus.
Fage C; Pizzorno A; Rhéaume C; Abed Y; Boivin G
J Med Virol; 2017 Dec; 89(12):2239-2243. PubMed ID: 28792077
[TBL] [Abstract][Full Text] [Related]
6. In vivo ribavirin activity against severe pandemic H1N1 Influenza A/Mexico/4108/2009.
Rowe T; Banner D; Farooqui A; Ng DC; Kelvin AA; Rubino S; Huang SS; Fang Y; Kelvin DJ
J Gen Virol; 2010 Dec; 91(Pt 12):2898-906. PubMed ID: 20797971
[TBL] [Abstract][Full Text] [Related]
7. Reduction of Neuraminidase Activity Exacerbates Disease in 2009 Pandemic Influenza Virus-Infected Mice.
Ranadheera C; Hagan MW; Leung A; Collignon B; Cutts T; Theriault S; Embury-Hyatt C; Kobasa D
J Virol; 2016 Nov; 90(21):9931-9941. PubMed ID: 27558428
[TBL] [Abstract][Full Text] [Related]
8. Combination Therapy with Oseltamivir and Favipiravir Delays Mortality but Does Not Prevent Oseltamivir Resistance in Immunodeficient Mice Infected with Pandemic A(H1N1) Influenza Virus.
Baz M; Carbonneau J; Rhéaume C; Cavanagh MH; Boivin G
Viruses; 2018 Nov; 10(11):. PubMed ID: 30400276
[TBL] [Abstract][Full Text] [Related]
9. Novel Ranking System for Identifying Efficacious Anti-Influenza Virus PB2 Inhibitors.
Tsai AW; McNeil CF; Leeman JR; Bennett HB; Nti-Addae K; Huang C; Germann UA; Byrn RA; Berlioz-Seux F; Rijnbrand R; Clark MP; Charifson PS; Jones SM
Antimicrob Agents Chemother; 2015 Oct; 59(10):6007-16. PubMed ID: 26169418
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of combined therapy with amantadine, oseltamivir, and ribavirin in vivo against susceptible and amantadine-resistant influenza A viruses.
Nguyen JT; Smee DF; Barnard DL; Julander JG; Gross M; de Jong MD; Went GT
PLoS One; 2012; 7(1):e31006. PubMed ID: 22292088
[TBL] [Abstract][Full Text] [Related]
11. Aerosol administration increases the efficacy of oseltamivir for the treatment of mice infected with influenza viruses.
Leyva-Grado VH; Palese P
Antiviral Res; 2017 Jun; 142():12-15. PubMed ID: 28286235
[TBL] [Abstract][Full Text] [Related]
12. Utilization of alpha-1-acid glycoprotein levels in the serum as a parameter for in vivo assay of influenza virus inhibitors.
Sidwell RW; Wong MH; Bailey KW; Barnard DL; Jackson MK; Smee DF
Antivir Chem Chemother; 2001 Nov; 12(6):359-65. PubMed ID: 12018681
[TBL] [Abstract][Full Text] [Related]
13. Synergistic activity of baicalein with ribavirin against influenza A (H1N1) virus infections in cell culture and in mice.
Chen L; Dou J; Su Z; Zhou H; Wang H; Zhou W; Guo Q; Zhou C
Antiviral Res; 2011 Sep; 91(3):314-20. PubMed ID: 21782851
[TBL] [Abstract][Full Text] [Related]
14. [In vivo efficacy of Ingavirin against pandemic A (H1N1/09)v influenza virus].
Shishkina LN; Nebol'sin VE; Skarnovich MO; Kabanov AS; Sergeev AA; Erdyneeva UB; Serova OA; Demina OK; Agafonov AP; Stavskiĭ EA; Drozdov IG
Antibiot Khimioter; 2010; 55(5-6):32-5. PubMed ID: 21033472
[TBL] [Abstract][Full Text] [Related]
15. Influenza A viruses of swine circulating in the United States during 2009-2014 are susceptible to neuraminidase inhibitors but show lineage-dependent resistance to adamantanes.
Baranovich T; Bahl J; Marathe BM; Culhane M; Stigger-Rosser E; Darnell D; Kaplan BS; Lowe JF; Webby RJ; Govorkova EA
Antiviral Res; 2015 May; 117():10-9. PubMed ID: 25701593
[TBL] [Abstract][Full Text] [Related]
16. Therapy of experimental influenza virus infection with pyrrolidine dithiocarbamate.
Wiesener N; Zimmer C; Jarasch-Althof N; Wutzler P; Henke A
Med Microbiol Immunol; 2011 May; 200(2):115-26. PubMed ID: 21174118
[TBL] [Abstract][Full Text] [Related]
17. Antiviral activity of Anaferon (pediatric formulation) in mice infected with pandemic influenza virus A(H1N1/09).
Shishkina LN; Skarnovich MO; Kabanov AS; Sergeev AA; Olkin SE; Tarasov SA; Belopolskaya MV; Sergeeva SA; Epstein OI; Malkova EM; Stavsky EA; Drozdov IG
Bull Exp Biol Med; 2010 Oct; 149(5):612-4. PubMed ID: 21165400
[TBL] [Abstract][Full Text] [Related]
18. Amantadine-oseltamivir combination therapy for H5N1 influenza virus infection in mice.
Ilyushina NA; Hoffmann E; Salomon R; Webster RG; Govorkova EA
Antivir Ther; 2007; 12(3):363-70. PubMed ID: 17591026
[TBL] [Abstract][Full Text] [Related]
19. Intravenous peramivir inhibits viral replication, and leads to bacterial clearance and prevention of mortality during murine bacterial co-infection caused by influenza A(H1N1)pdm09 virus and Streptococcus pneumoniae.
Onishi M; Kitano M; Taniguchi K; Homma T; Kobayashi M; Yoshinaga T; Naito A; Sato A
Antiviral Res; 2015 May; 117():52-9. PubMed ID: 25752738
[TBL] [Abstract][Full Text] [Related]
20. [Anti-viral activity of a complex of the glycyrrhizic acid-alpha-glutamyltryptophan against the experimental lethal influenza infection in white mice caused by the oseltamivir-resistant strain of the virus].
Smirnov VS; Garshinina AV; Shtro AA; Anikin VB; Galochkina AV; Beliavskaia SV; Zarubaev VV
Vopr Virusol; 2014; 59(5):31-8. PubMed ID: 25895209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
